Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hip OA

Dr. Sara Alehashemi: Rheumatologist, Researcher & Badminton Player

Carol Patton  |  March 18, 2019

Sara Alehashemi, MD, MPH, recalls the first time she ever stepped foot on a badminton court. It was back in 2003, when she was a 24-year-old medical school student at Hormozgan University of Medical Sciences (HUMS) in Iran. She was completing a rotation in orthopedic surgery and had been teamed up with another medical student…

Filed under:AudioProfilesRheum After 5 Tagged with:Dr. Sara Alehashemi

The ACR De-Fragments & Analyzes Its Data to Identify Member Needs

Paula Marchetta, MD, MBA  |  March 18, 2019

The ACR recognizes that data are more important now than ever. As we enter what has been called the Fourth Industrial Revolution—a period of digitalization in which technology is embedded everywhere in our everyday lives—we are not just hearing constantly about the importance of data and its capabilities, we are experiencing it every day, firsthand…

Filed under:Education & TrainingInformation TechnologyPresident's PerspectiveTechnologyTechnology Tagged with:ACR Data Steering Committeedata

The Benefits of Blood Money: OxyContin & Ethics

Philip Seo, MD, MHS  |  March 18, 2019

On Feb. 9, 2019, protesters gathered at the Guggenheim Museum in New York City to lead a march down Fifth Avenue to the Metropolitan Museum of Art.1 As a general rule, news from the world of art is not a topic discussed in these pages, but if you indulge me for just a little bit…

Filed under:EthicsOpinionRheuminationsSpeak Out Rheum Tagged with:Arthur M. Sackler FoundationDr. Mortimer and Theresa Sackler Foundationopioid crisisopioid use disordersOxyContinPurdue PharmaRaymond and Beverly Sackler Foundation

Calcineurin Inhibitor Pain Syndrome: A Case Report & Literature Review

Priyanka Iyer, MD, MPH  |  March 18, 2019

CHICAGO—Medications have frequently been implicated as a cause of musculoskeletal complaints, including persistent arthralgias, arthritis and myalgias.1 The list of offending agents is diverse, and the degree of symptoms is variable. In the world of transplant recipients, this list is exhaustive and includes immunosuppressive agents (cyclosporine, tacrolimus); myeloid growth factors, such as G-CSF; antibiotics (quinolones);…

Filed under:ConditionsMeeting Reports Tagged with:2018 ACR/ARHP Annual Meetingcalcineurin inhibitorcalcineurin inhibitor pain syndromeimmunosuppressive drugs

New Study: Does Urate-Lowering Therapy Reduce Gout-Patient Mortality?

New Study: Does Urate-Lowering Therapy Reduce Gout-Patient Mortality?

Ruth Jessen Hickman, MD  |  March 18, 2019

Results of a recent study in Arthritis & Rheumatology fail to clarify whether urate-lowering therapies may potentially reduce mortality risk in patients with gout.1 The study also underscores the fact that many physicians are not following the ACR guideline to help their patients achieve target serum urate levels. Partly because of this, it remains unclear…

Filed under:ConditionsGout and Crystalline ArthritisResearch Rheum Tagged with:Allopurinolurate-lowering therapies

Research Suggests Th17 Cells Have Microbiota-Dependent Role in RA

Kathy Holliman  |  March 18, 2019

A growing body of research is elucidating the role of intestinal microbiota in several auto­immune diseases, including rheumatoid arthritis (RA). Research published in December 2018 Arthritis & Rheumatology increases our understanding of the “extent and nature of mucosal immune activation during preclinical arthritis.”1 The research objective, according to the report, was to “dissect intestinal mucosal immune…

Filed under:ConditionsResearch RheumRheumatoid Arthritis Tagged with:IL-17 CytokineMicrobiomeTh17

tanuha2001 / shutterstock.com

Fellows Forum: Helpful Twitter Follows & Chats for Fellows in Training

Kanika Monga, MD  |  March 18, 2019

We spend a good portion of our day in front of screens—televisions, computers, tablets, phones and more. Social media (#SoMe) use has been on the rise, and its marriage to medicine seems inevitable. Merriam-Webster, aka America’s most trusted online dictionary, defines social media as forms of electronic communication through which users create online communities to…

Filed under:AppsTechnologyTechnology Tagged with:FellowsFellows ForumSocial MediaTwitter

Lightspring / shutterstock.com

Recent Research Probes Smoking & the Risk for Autoimmune Disease

Vanessa Caceres  |  March 18, 2019

It’s no secret to any health professional, including rheumatologists, that smoking cigarettes or using other tobacco-based products is unhealthy. Yet how does smoking specifically affect rheumatic diseases, and what are some of the newest findings in this area? What role do e-cigarettes have in the smoking risk landscape? Those are the sorts of questions asked…

Filed under:Conditions Tagged with:cigaretteSmoking

Happiness in Rheumatology

Richard Quinn  |  March 12, 2019

A 2019 report says rheumatologists are the happiest medical specialists outside of work. Simon Helfgott, MD, says this finding shows “we have been able to blend an interesting, intellectually stimulating profession and practice with the ability to help people.”..

Filed under:Professional Topics

U.S. FDA Chief Gottlieb Resigns

Yasmeen Abutaleb  |  March 5, 2019

WASHINGTON (Reuters)—U.S. Food and Drug Administration (FDA) Chief Scott Gottlieb said he plans to step down in a month, calling into question how the agency will handle critical issues, such as e-cigarette use among teens and efforts to increase competition in prescription drugs. The U.S. Department of Health and Human Services (HHS), which oversees the…

Filed under:Professional Topics Tagged with:FDAFDA Commissioner Scott GottliebFood and Drug AdministrationU.S. Food and Drug Administration (FDA)

  • « Previous Page
  • 1
  • …
  • 150
  • 151
  • 152
  • 153
  • 154
  • …
  • 330
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences